Russell Investments Group’s Exagen XGN Stock Holding History
Bought
Maintained
Sold
Other funds holding XGN
WC
VCM
NCNMGF
SAM
KCM
FCM
RI
MBAM
Russell Investments Group's XGN Position: Q1 2026 in Review
Russell Investments Group sold out of Exagen (XGN) in Q1 2026, closing a stake of 187,922 shares — an estimated $1.14M sold.
Russell Investments Group first reported a position in XGN in Q3 2019 and held it in 14 quarters. The position peaked at $2.91M in Q4 2019. 61 funds tracked by Wall St. Rank hold XGN as of Q1 2026.
- Russell Investments Group reported no remaining Exagen position as of Q1 2026 after selling out during the quarter.
- Russell Investments Group sold 187,922 Exagen shares in Q1 2026, an estimated $1.14M.
- Russell Investments Group first reported a position in Exagen in Q3 2019 and held it in 14 quarters.
- Russell Investments Group's Exagen position peaked at $2.91M in Q4 2019.
- 61 funds tracked by Wall St. Rank held Exagen as of Q1 2026.
Based on Russell Investments Group's 13F filing for Q1 2026, filed 8 May 2026.